Steroids

Forward: A history of steroid chemistry
pp. 438-438(1)
Author: Petrow V.

The steroid story of Jenapharm: From the late 1940s to the early 1970s
pp. 439-445(7)
Authors: Schwarz S.; Onken D.; Schubert A.

Midgestational maternal urine steroid markers of fetal Smith-Lemli-Opitz (SLO) syndrome (7-dehydrocholesterol 7-reductase deficiency)
pp. 446-452(7)
Authors: Shackleton C.H.L.; Roitman E.; Kratz L.E.; Kelley R.I.

Lipoprotein lipase promoting agent, NO-1886, modulates adrenal functions: species difference in effects of NO-1886 on steroidogenesis
pp. 453-459(7)
Authors: Shimono K.; Tsutsumi K.; Yaguchi H.; Omura M.; Sasano H.; Nishikawa T.

17-Hydroxy-11-(3'-sulfanylpropyl)oxy-estra-1,3,5(10)-trien-3-yl sulfamate - a novel hapten structure: toward the development of a specific enzyme immunoassay (EIA) for estra-1,3,5(10)-triene-3-yl sulfamates
pp. 460-471(12)
Authors: Schwarz S.; Schumacher M.; Nanninga A.; Weber G.; Thieme I.; Undeutsch B.; Elger W.

Inhibition of estrogen receptor function promotes porcine coronary artery smooth muscle cell proliferation
pp. 472-480(9)
Authors: Lavigne M.C.; Ramwell P.W.; Clarke R.

Neonatal urinary steroids in Smith-Lemli-Opitz syndrome associated with 7-dehydrocholesterol reductase deficiency
pp. 481-490(10)
Authors: Shackleton C.H.L.; Roitman E.; Kelley R.

Preparation of specific antisera to 15-hydroxyestrogen 15-N-acetylglucosaminides
pp. 491-496(6)
Authors: Nakagomi M.; Iida S.; Hara Y.; Matsuki Y.; Nambara T.; Suzuki E.

Erratum to 'Ergosteroids II: biologically active metabolites and synthetic derivatives of dehydroepiandrosterone' [Steroids 63 (1998) 158-165]
pp. 497-497(1)
Authors: Lardy H.; Kneer N.; Wei Y.; Partridge B.; Marwah P.